Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term Outcomes
Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY
This is a prospective, tissue-based, low-risk, non-pharmacological study that will include adult patients undergoing solid organ transplantation (heart, liver, lung, kidney) followed at the following Units of the IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO): * Heart Failure and Transplants (heart-lung) * Internal Medicine for the Treatment of Severe Organ Failures (liver) * Nephrology, Dialysis, and Transplantation (kidney).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult patients (≥ 18 years old at the time of enrollment) who have undergone at least one of the following: Liver transplant, Kidney transplant, Heart transplant, Lung transplant during the study period.
• Informed consent acquisition.
Locations
Other Locations
Italy
IRCCS - Azienda ospedaliero-universitaria di Bologna
RECRUITING
Bologna
IRCCS - Azienda ospedaliero-universitaria di Bologna
RECRUITING
Bologna
IRCCS - Azienda ospedaliero-universitaria di Bologna
RECRUITING
Bologna
Contact Information
Primary
Marco Masetti, MD
scompenso.trapiantocuore@aosp.bo.it
0512143725
Time Frame
Start Date: 2024-10-10
Estimated Completion Date: 2031-12
Participants
Target number of participants: 250
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna